Processa Pharmaceuticals, Inc.
PCSA
$0.2294
-$0.0059-2.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -58.80% | -48.10% | -37.55% | 89.55% | -31.40% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -64.95% | 2.09% | 122.35% | -7.42% | -11.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -61.27% | -35.30% | -23.70% | 74.00% | -28.77% |
|
|
|||||
| Total Current Assets | -61.27% | -35.30% | -23.70% | 74.00% | -28.77% |
| Net Property, Plant & Equipment | -23.15% | -16.17% | -15.41% | -6.53% | -12.43% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23,172.73% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -34.66% | -34.98% | -23.57% | 71.86% | -28.41% |
|
|
|||||
| Total Accounts Payable | 23.77% | -25.33% | 109.29% | 46.15% | -10.02% |
| Total Accrued Expenses | 40.19% | -18.32% | 8.55% | 218.25% | -27.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -22.91% | 1.61% | 3.90% | 7.30% | 1.09% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -2.98% |
| Total Other Current Liabilities | -- | -- | -- | -- | -2.98% |
| Total Current Liabilities | 25.71% | -21.43% | 53.53% | 38.34% | -11.56% |
|
|
|||||
| Total Current Liabilities | 25.71% | -21.43% | 53.53% | 38.34% | -11.56% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -77.27% | -91.41% | -49.51% | -24.22% | -24.66% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 25.52% | -22.56% | 48.61% | 33.09% | -12.82% |
|
|
|||||
| Common Stock & APIC | 0.80% | 1.24% | 0.17% | 8.21% | 0.28% |
| Retained Earnings | -3.23% | -4.17% | -3.85% | -3.62% | -3.30% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -54.41% | -38.23% | -32.19% | 78.05% | -30.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -54.41% | -38.23% | -32.19% | 78.05% | -30.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -54.41% | -38.23% | -32.19% | 78.05% | -30.40% |
|
|
|||||